ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $928,000 | +472.8% | 5,391 | +217.9% | 0.02% | +155.6% |
| Q2 2020 | $162,000 | +1925.0% | 1,696 | +987.2% | 0.01% | – |
| Q4 2019 | $8,000 | +300.0% | 156 | +164.4% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 59 | -3.3% | 0.00% | – |
| Q2 2019 | $3,000 | -97.9% | 61 | -98.0% | 0.00% | -100.0% |
| Q1 2019 | $145,000 | -88.6% | 3,109 | -86.0% | 0.01% | -89.2% |
| Q3 2018 | $1,274,000 | +129.5% | 22,263 | +94.7% | 0.07% | +111.4% |
| Q2 2018 | $555,000 | +2821.1% | 11,437 | +2187.4% | 0.04% | +1066.7% |
| Q1 2015 | $19,000 | -44.1% | 500 | -50.0% | 0.00% | -25.0% |
| Q2 2014 | $34,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,240,173 | $31,649,000 | 3.01% |
| NEXTHERA CAPITAL LP | 178,000 | $4,543,000 | 2.66% |
| AlpInvest Partners B.V. | 23,272 | $594,000 | 2.10% |
| HARBOURVEST PARTNERS LLC | 211,928 | $5,408,000 | 1.64% |
| HAMILTON LANE ADVISORS LLC | 92,990 | $2,373,000 | 1.56% |
| Perceptive Advisors | 619,987 | $15,822,000 | 1.12% |
| SECTORAL ASSET MANAGEMENT INC | 345,225 | $8,810,000 | 0.98% |
| Casdin Capital, LLC | 45,000 | $1,148,000 | 0.95% |
| Iguana Healthcare Management, LLC | 60,000 | $1,531,000 | 0.92% |
| OAK RIDGE INVESTMENTS LLC | 1,002,334 | $25,580,000 | 0.83% |